Toll-like receptor 2 induces th17 myeloperoxidase autoimmunity while toll-like receptor 9 drives th1 autoimmunity in murine vasculitis

Arthritis and Rheumatism

Volumn 63, Issue 4, 2011, Pages 1124-1135

  Summers, Shaun A ^a   Steinmetz, Oliver M ^a   Gan, Poh Yi ^a   Ooi, Joshua D ^a   Odobasic, Dragana ^a   Kitching, A Richard ^a   Holdsworth, Stephen R ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 17 ANTIBODY; MYELOPEROXIDASE; ORPHAN NUCLEAR RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9;

ANCA ASSOCIATED VASCULITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; GLOMERULONEPHRITIS; GLOMERULUS; HUMORAL IMMUNITY; IMMUNIZATION; KIDNEY NECROSIS; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; WILD TYPE;

ANIMALS; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, MONOCLONAL; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS; IMMUNITY, HUMORAL; INTERFERON-GAMMA; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEROXIDASE; TH1 CELLS; TH17 CELLS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 9;

EID: 79953677803     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30208     Document Type: Article

References (40)

1. Goodnow CC. Multistep pathogenesis of autoimmune disease. Cell 2007;130:25-35 (Pubitemid 47031326)
2. Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995;16:34-8
3. Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of TH17 cells. Nature 2008;453:1051-7 (Pubitemid 351871737)
4. Walton E. Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J 1958;2:265-70
5. Abdulahad WH, Stegeman CA, van der Geld YM, Doornbosvan der Meer B, Limburg PC, Kallenberg CG. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2007;56:2080-91 (Pubitemid 47110408)
6. Abdulahad WH, van der Geld YM, Stegeman CA, Kallenberg CG. Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis. Kidney Int 2006;70:938-47 (Pubitemid 44285972)
7. Abdulahad WH, Stegeman CA, CG Kallenberg CG. Review article: the role of CD4+ T cells in ANCA-associated systemic vasculitis. Nephrology (Carlton) 2009;14:26-32
8. Brouwer E, Huitema MG, Klok PA, de Weerd H, Tervaert JW, Weening JJ, et al. Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model. J Exp Med 1993;177:905-14 (Pubitemid 23097380)
9. Kessenbrock K, Krumbholz M, Schonermarck U, Back W, Gross WL, Werb Z, et al. Netting neutrophils in autoimmune smallvessel vasculitis. Nat Med 2009;15:623-5
10. Ruth AJ, Kitching AR, Kwan RY, Odobasic D, Ooi JD, Timoshanko JR, et al. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in antimyeloperoxidase crescentic glomerulonephritis. J Am Soc Nephrol 2006;17:1940-9 (Pubitemid 44036178)
11. Yoshida M, Iwahori T, Nakabayashi I, Akashi M, Watanabe T, Yoshikawa N. In vitro production of myeloperoxidase antineutrophil cytoplasmic antibody and establishment of Th1-type T cell lines from peripheral blood lymphocytes of patients. Clin Exp Rheumatol 2005;23:227-30 (Pubitemid 40663004)
12. Abdulahad WH, Stegeman CA, Limburg PC, Kallenberg CG. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2008;58: 2196-205 (Pubitemid 351988114)
13. Nogueira E, Hamour S, Sawant D, Henderson S, Mansfield N, Chavele KM, et al. Serum IL-17 and IL-23 levels and autoantigenspecific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 2010;25:2209-17
14. Tidman M, Olander R, Svalander C, Danielsson D. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies. J Intern Med 1998;244:133-41 (Pubitemid 28364798)
15. Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG, for the Dutch Co-Trimoxazole Wegener Study Group. Trimethoprim- sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 1996;335:16-20
16. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004;5:987-95 (Pubitemid 41057715)
17. Li M, Zhou Y, Feng G, Su SB. The critical role of Toll-like receptor signaling pathways in the induction and progression of autoimmune diseases. Curr Mol Med 2009;9:365-74
18. Shirali AC, Goldstein DR. Tracking the toll of kidney disease. J Am Soc Nephrol 2008;19:1444-50
19. Apostolopoulos J, Ooi JD, Odobasic D, Holdsworth S.R, Kitching AR. The isolation and urification of biologically active recombinant and native autoantigens for the study of autoimmune disease. J Immunol Methods 2006;308:167-78 (Pubitemid 43107963)
20. Kitching AR, Tipping PG, Kurimoto M, Holdsworth SR. IL-18 has IL-12-independent effects in delayed-type hypersensitivity: studies in cell-mediated crescentic glomerulonephritis. J Immunol 2000; 165:4649-57
21. Phoon RK, Kitching AR, Odobasic D, Jones LK, Semple TJ, Holdsworth SR. T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis. J Am Soc Nephrol 2008;19: 477-85 (Pubitemid 351355391)
22. Summers SA, Steinmetz OM, Li M, Kausman JY, Semple T, Edgtton KL, et al. Th1 and Th17 cells induce proliferative glomerulonephritis. J Am Soc Nephrol 2009;20:2518-24
23. Gan PY, Steinmetz OM, Tan DS, O'Sullivan KM, Ooi JD, Iwakura Y, et al. Th17 cells promote autoimmune antimyeloperoxidase glomerulonephritis. J Am Soc Nephrol 2010;21: 925-31
24. Brown HJ, Lock HR, Sacks SH, Robson MG. TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis. J Immunol 2006;177:1925-31 (Pubitemid 44092533)
25. Pawar RD, Patole PS, Ellwart A, Lech M, Segerer S, Schlondorff D, et al. Ligands to nucleic acid-specific Toll-like receptors and the onset of lupus nephritis. J Am Soc Nephrol 2006;171:3365-73 (Pubitemid 44865279)
26. Janeway CA Jr, Medzhitov R. Introduction: the role of innate immunity in the adaptive immune response. Semin Immunol 1998;10:349-50 (Pubitemid 28499547)
27. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335-76 (Pubitemid 37174535)
28. Hansen BS, Hussain RZ, Lovett-Racke AE, Thomas JA, Racke MK. Multiple Toll-like receptor agonists act as potent adjuvants in the induction of autoimmunity. J Neuroimmunol 2006;172:94-103 (Pubitemid 43277494)
29. Reynolds JM, Pappu BP, Peng J, Martinez GJ, Zhang Y, Chung Y, et al. Toll-like receptor 2 signaling in CD4+ T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. Immunity 2010;32:692-702
30. Krug A, Towarowski A, Britsch S, Rothenfusser S, Hornung V, Bals R, et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol 2001;31:3026-37 (Pubitemid 32994554)
31. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000;408: 740-5 (Pubitemid 32015992)
32. Prinz M, Garbe F, Schmidt H, Mildner A, Gutcher I, Wolter K, et al. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest 2006;116: 456-64 (Pubitemid 43228363)
33. Kubo T, Uchida Y, Watanabe Y, Abe M, Nakamura A, Ono M, et al. Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity. J Exp Med 2009;206:1971-82
34. Baudino L, Azeredo da Silveira S, Nakata M, Izui S. Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies. Springer Semin Immunopathol 2006;28:175-84 (Pubitemid 46628484)
35. Pinching AJ, Rees AJ, Pussell BA, Lockwood CM, Mitchison RS, Peters DK. Relapses in Wegener's granulomatosis: the role of infection. Br Med J 1980;281:836-8 (Pubitemid 10059945)
36. Capizzi SA, Specks U. Does infection play a role in the pathogenesis of pulmonary vasculitis? Semin Respir Infect 2003;18:17-22 (Pubitemid 36373412)
37. Arimura Y, Minoshima S, Kamiya Y, Tanaka U, Nakabayashi K, Kitamoto K, et al. Serum myeloperoxidase and serum cytokines in anti-myeloperoxidase antibody-associated glomerulonephritis. Clin Nephrol 1993;40:256-64 (Pubitemid 23333356)
38. Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CG. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994;120:12-7 (Pubitemid 24011495)
39. Tipping PG, Holdsworth SR. T cells in crescentic glomerulonephritis. J Am Soc Nephrol 2006;17:1253-63 (Pubitemid 43673405)
40. Kuligowski MP, Kitching AP, Hickey MJ. Leukocyte recruitment to the inflamed glomerulus: a critical role for plateletderived P-selectin in the absence of rolling. J Immunol 2006; 176:6991-9 (Pubitemid 43787879)